Food and drug litigation strategies
Subtitle: leading lawyers on building strong defenses and adapting to evolving FDA regulations
Series: Inside the minds
Publisher: Aspatore
Published: 2013
Place of publication: United States]
Language: eng
Number of pages: 168
ISBN-13: 9780314290854
Subjects: Drugs; Defense (Civil procedure); Law and legislation; Food law and legislation
Notes: Includes bibliographical references.
Table of contents: title: Jonathan Berman, Partner, Jones Day -"Helping Food Companies Avoid and Defend Against Product Mislabeling Class Actions"; title: Kevin M. Nelson, Partner, Duane Morris LLP - "What You Need to Know to Play the Pharmaceutical Patent Litigation Game : Best Practices, Emerging Trends, and Changes in the Generic Drug and Biosimilars World"; title: Michael F. Ruggio, Shareholder, LeClair Ryan - "More Products and Issues, Fewer FDA Resources"; title: Reed D. Rubinstein, Partner, Dinsmore & Shohl LLP - "Defending What Matters : Effectively Handling Food and Drug Claims in a Dynamic Regulatory and Public Relations Environment"; title: Van H. Beckwith, Partner, Baker Botts LLP - "Litigating Food and Beverage Labeling Cases: Some Strategies and Trends"; title: Felicia Leborgne Nowels, Shareholder, Akerman Senterfit - "Current Preemption Issues in FDA Litigation : What's a Manufacturer to Do?  : Follow the Law - But Pay Close Attention to Future Changes in the Law"; title: Lorraine E.J. Gallagher, Partner, Wilson Elser Moskowitz Edelman & Dicker LLP - "FDA-Approved Products : Strategies for Defending a Recalled Product"; title: Daniel S. Wittenberg, Partner, Snell & Wilmer LLP - "Impacts of the FDASIA and Recent Food and Drug Law Litigation"; title: Bruce S. Manheim Jr., Partner, Wilmer Cutler Pickering Hale and Dorr LLP - "A Primer : Recent Developments and Strategies in Petitions and Lawsuits Challenging FDA Approval of Generic Drug Products Under the Administrative Procedure Act".